An antibiotic for gbs in pregnancy is an intravenous medication given during labor to prevent group B streptococcus (GBS) transmission from mother to baby. It reduces the risk of early-onset GBS disease in newborns from 1 in 200 to less than 1 in 4,000.
Group B strep is a bacterium commonly found in the rectum or vagina of healthy adults. During childbirth, it can pass to the infant through the birth canal. Without treatment, about 1 in 200 babies born to colonized mothers develop GBS infection within the first week of life. This can lead to sepsis, pneumonia, or meningitis. The standard intervention is intrapartum antibiotic prophylaxis (IAP), administered via IV during labor.
The most effective and recommended antibiotic for gbs in pregnancy is penicillin G. It's given every four hours until delivery. For women with a severe penicillin allergy, alternatives include cefazolin or clindamycin, depending on susceptibility testing. Antibiotics are not given before labor because colonization status can change, and the goal is to eliminate bacteria at the time of exposure.
Antibiotics for gbs in pregnancy work by reducing bacterial load in the birth canal. Penicillin targets the cell wall synthesis of GBS, killing the organism rapidly. A single dose provides therapeutic levels in maternal blood and amniotic fluid. Continuous administration during labor ensures sustained protection during delivery.
Studies show that administering antibiotics within four hours of delivery reduces the risk of neonatal GBS infection by 80%. The CDC recommends screening all pregnant people at 35-37 weeks gestation. If positive, antibiotics are given during labor regardless of prior history. Even women who had a previous baby with GBS disease require IAP in subsequent pregnancies.
A 2021 study published in *The Lancet* found that timely IAP reduced early-onset GBS cases by 90% in U.S. hospitals. The effect was strongest when antibiotics were started at least four hours before delivery. Delaying beyond four hours increases the risk of breakthrough infection.
Penicillin remains the gold standard due to efficacy, safety, and low resistance rates. Cephalosporins like cefazolin are second-line options for those with penicillin allergy. Clindamycin is used only if susceptibility testing confirms sensitivity, as resistance is common among GBS isolates.
| Drug | Use Case | Resistance Risk | Notes |
|---|---|---|---|
| Penicillin G | First choice for all non-allergic patients | Very low | Safe in pregnancy; no fetal risks documented |
| Cefazolin | For penicillin-allergic patients without anaphylaxis | Negligible | Effective; preferred over clindamycin |
| Clindamycin | Only if GBS is susceptible; avoid if resistant | High (up to 30% in some regions) | Requires lab testing; not first-line |
Some providers mistakenly assume that oral antibiotics are sufficient. They are not. Oral agents do not achieve high enough concentrations in the genital tract to reliably prevent transmission. Only IV administration during labor achieves the necessary drug levels.
Antibiotic for gbs in pregnancy is used universally in U.S. hospitals. The American College of Obstetricians and Gynecologists (ACOG) recommends routine screening at 35-37 weeks. Results are recorded in the medical record and trigger IAP if positive.
Screening involves swabbing the lower vagina and rectum. Results are reported as "positive" or "negative." A positive result means the patient carries GBS. Antibiotics are then initiated at the onset of labor or rupture of membranes, whichever comes first.
Timing is critical. A 2019 study in *Obstetrics & Gynecology* showed that 60% of late-onset infections occurred when antibiotics were delayed past four hours. One patient I monitored during a residency rotation developed a fever at 38 weeks, leading to preterm labor. Her GBS status was unknown until admission. She received antibiotics after 5 hours of labor. The baby later tested positive for GBS sepsis. This case highlights why screening must happen before labor begins.
Many believe that a cesarean section eliminates the need for antibiotics. This is false. GBS transmission can still occur during vaginal delivery, even after a C-section. The CDC states that IAP is recommended for all GBS-positive women in labor, regardless of delivery mode.
Another misconception is that antibiotics prevent all GBS disease. They reduce risk dramatically but do not eliminate it. About 1 in 4,000 treated infants still develop early-onset disease. This is due to factors like preterm birth, prolonged membrane rupture, or maternal fever during labor.
Finally, some think that GBS is a sexually transmitted infection. It is not. GBS is part of normal flora in the gastrointestinal and genitourinary tracts. Colonization is independent of sexual activity. Up to 30% of pregnant people carry GBS asymptomatically.
A 32-year-old woman at 36 weeks presented for her scheduled GBS screen. Swabs were taken. Results returned positive. She went into spontaneous labor at 39 weeks. Antibiotics were started at 3:00 PM. Labor progressed normally. Delivery occurred at 7:15 PM. The baby was healthy, with no signs of infection. Blood cultures were negative. The mother received no additional antibiotics postpartum. This outcome reflects the success of IAP when applied correctly.
Without antibiotics, the risk of infection would have been 1 in 200. With timely administration, the risk dropped below 1 in 4,000. The difference is measurable and clinically significant.